DeJesus, E. ., Haas, B. ., Segal-Mauer, S. ., Ramgopal, M. ., Mills, A. ., Margot, N. ., … McCallister, S. . (2018). Superior Efficacy and Improved Renal and Bone Safety After Switching From a Tenofovir Disoproxil Fumarate (TDF)- to a Tenofovir Alafenamide (TAF)-based Regimen Through 96 Weeks of Treatment. AIDS Research and Human Retroviruses. https://doi.org/10.1089/AID.2017.0203 (Original work published 2018)